Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy

被引:60
|
作者
Wang, Chenwei [1 ,2 ]
He, Wei [1 ,2 ]
Yuan, Yichuan [1 ,2 ]
Zhang, Yuanping [1 ,2 ]
Li, Kai [1 ,2 ]
Zou, Ruhai [1 ,3 ]
Liao, Yadi [1 ,2 ]
Liu, Wenwu [1 ,2 ]
Yang, Zhiwen [1 ,2 ]
Zuo, Dinglan [1 ]
Qiu, Jiliang [1 ,2 ]
Zheng, Yun [1 ,2 ]
Li, Binkui [1 ,2 ]
Yuan, Yunfei [1 ,2 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Hepatobiliary Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Ultrasound, Canc Ctr, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
early recurrent hepatocellular carcinoma; inflammation-based prognostic score; prognosis predictor; systemic immune-inflammation index; INDEX PREDICTS; CANCER; RESECTION; IMPACT; RATIO;
D O I
10.1111/liv.14281
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims Inflammation-based prognostic scores, such as the Glasgow Prognostic Score (GPS), modified Glasgow Prognostic Score (mGPS), Prognostic Index (PI), Prognostic Nutritional Index (PNI), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR) and systemic immune-inflammation index (SII), are correlated with the survival of hepatocellular carcinoma (HCC) patients, while remain unclear for recurrent HCC. This study aimed to compare the prognostic value of inflammation-based prognostic scores for post-recurrence survival (PRS) in patients with early recurrent HCC (ErHCC, within 2 years after hepatectomy). Methods A total of 580 patients with ErHCC were enrolled retrospectively. The association between the independent baseline and the time-dependent variables and PRS was evaluated by cox regression. The prediction accuracy of the inflammation-based prognostic scores was assessed by time-dependent receiver operating characteristic (ROC) and Harrell's concordance index (C-index) analyses. Results The GPS, mGPS, PI, PNI, NLR, PLR, LMR and SII were all related to the PRS of ErHCC patients, while only the SII (P < .001) remained an independent predictor for PRS in multivariate analysis (hazard ratio: 1.92, 95% confidence interval: 1.33-2.79). Both the C-index of the SII (0.65) and the areas under the ROC curves showed that the SII score was superior to the other inflammation-based prognostic scores for predicting the PRS of ErHCC patients. Conclusions The SII is a useful prognostic indicator for PRS in patients with ErHCC after hepatectomy and is superior to the other inflammation-based prognostic scores in terms of prognostic ability.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 50 条
  • [1] Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
    Kinoshita, A.
    Onoda, H.
    Imai, N.
    Iwaku, A.
    Oishi, M.
    Fushiya, N.
    Koike, K.
    Nishino, H.
    Tajiri, H.
    BRITISH JOURNAL OF CANCER, 2012, 107 (06) : 988 - 993
  • [2] Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
    A Kinoshita
    H Onoda
    N Imai
    A Iwaku
    M Oishi
    N Fushiya
    K Koike
    H Nishino
    H Tajiri
    British Journal of Cancer, 2012, 107 : 988 - 993
  • [3] The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy
    Junting Huang
    Li Xu
    Yaoling Luo
    Fengying He
    Yaojun Zhang
    Minshan Chen
    Medical Oncology, 2014, 31
  • [4] Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
    Mei, Jie
    Sun, Xu-Qi
    Lin, Wen-Ping
    Li, Shao-Hua
    Lu, Liang-He
    Zou, Jing-Wen
    Wei, Wei
    Guo, Rong-Ping
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 3879 - 3890
  • [5] Inflammation-Based Scores and Hepatocellular Carcinoma
    Parisi, Ioanna
    O'Beirne, James
    Tsochatzis, Emmanuel
    LIVER TRANSPLANTATION, 2014, 20 (12) : 1529 - 1529
  • [6] The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib
    Conroy, Guillaume
    Salleron, Julia
    Belle, Arthur
    Bensenane, Mouni
    Nani, Abdelbasset
    Ayav, Ahmet
    Peiffert, Didier
    Lopez, Anthony
    Baumann, Cedric
    Barraud, Helene
    Bronowicki, Jean-Pierre
    ONCOTARGET, 2017, 8 (56) : 95853 - 95864
  • [7] Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection
    Yamamura, Kazuo
    Sugimoto, Hiroyuki
    Kanda, Mitsuro
    Yamada, Suguru
    Nomoto, Shuji
    Nakayama, Goro
    Fujii, Tsutomu
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (09) : 682 - 688
  • [8] Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma
    Weihao Kong
    Mingwei Yang
    Jianfeng Zhang
    Ya Cheng
    Tianxing Dai
    Jian Zhang
    Guoying Wang
    Jianlin Zhang
    BMC Cancer, 21
  • [9] Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma
    Kong, Weihao
    Yang, Mingwei
    Zhang, Jianfeng
    Cheng, Ya
    Dai, Tianxing
    Zhang, Jian
    Wang, Guoying
    Zhang, Jianlin
    BMC CANCER, 2021, 21 (01)
  • [10] Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy
    Yue Liu
    Zhong-Xia Wang
    Yin Cao
    Guang Zhang
    Wei-Bo Chen
    Chun-Ping Jiang
    Hepatobiliary&PancreaticDiseasesInternational, 2016, 15 (03) : 266 - 274